Agnes Figueras
Gran Via 199-203
Barcelona, CT 08908, Spain
Barcelona, CT 08908, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 09, 2026
Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.
Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.
Journal: International journal of cancer
Published: July 28, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment.
Journal: NAR cancer
Published: October 17, 2024
Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread.
Journal: Molecular oncology
Published: August 17, 2023
Glucose deprivation drives LIF-dependent lung cancer.
Journal: Nature metabolism
Published: May 15, 2022
PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner.
Journal: Cancer & metabolism
Published: July 17, 2020
PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.
Journal: Cells
Published: July 31, 2019
Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 22, 2019
Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
Journal: Molecular oncology
Published: May 22, 2019
ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 31, 2017
Last Updated: 09/26/2026